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The sensing of various extrinsic stimuli triggers the receptor-interacting protein kinase-3 
(RIPK3)-mediated signaling pathway, which leads to mixed-lineage kinase-like (MLKL) 
phosphorylation followed by necroptosis. Although necroptosis is a form of cell death and is 
involved in inflammatory conditions, the roles of necroptosis in acute pancreatitis (AP) remain 
unclear. In the current study, we administered caerulein to Ripk3- or Mlkl-deficient mice (Ripk3-
/- or Mlkl-/- mice, respectively) and assessed the roles of necroptosis in AP. We found that 
Ripk3-/- mice had significantly more severe pancreatic edema and inflammation associated with 
macrophage and neutrophil infiltration than control mice. Consistently, Mlkl-/- mice were more 
susceptible to caerulein-induced AP, which occurred in a time- and dose-dependent manner, 
than control mice. Mlkl-/- mice exhibit weight loss, edematous pancreatitis, necrotizing 
pancreatitis, and acinar cell dedifferentiation in response to tissue damage. Genetic deletion of 
Mlkl resulted in downregulation of the antiapoptotic genes Bclxl and Cflar in association with 
increases in the numbers of apoptotic cells, as detected by TUNEL assay. These findings suggest 
that RIPK3 and MLKL-mediated necroptosis exerts protective effects in AP and caution against 







Necroptosis is a necrotic form of programmed cell death that is involved in various 
inflammatory pathologies 1 2. The protein kinase receptor-interacting protein kinase 1 (RIPK1) is 
an upstream signaling molecule that is shared by both apoptosis and necroptosis,  and caspase 8 is 
the critical switch that determines whether cells die by apoptosis or necroptosis 2 3 4 5. Upon 
binding of ligands to cell surface receptors such as TLRs or TNFRs, RIPK1 interacts with 
receptor-interacting protein kinase 3 (RIPK3) through the RIP homotypic interaction motif to 
form a necrosome complex 5. Phosphorylated RIPK3 phosphorylates mixed lineage kinase 
domain-like (MLKL) through a C-terminal kinase-like domain 6 7. Phosphorylated MLKL 
undergoes a conformational change in the N-terminal four-helix bundle domain, which forms a 
tetrameric complex 2 6. The MLKL tetramer further translocates to the plasma membrane and 
oligomerizes to induce pore formation, resulting in sodium influx, osmotic pressure changes, and 
cell lysis 8. The release of intracellular proteins, including various damage-associated molecular 
patterns, creates a microenvironment that recruits inflammatory immune cells, leading to 
uncontrolled inflammation 6. Recent studies have demonstrated the contribution of necroptosis 
to various inflammatory diseases 2 9 10, and we have revealed that increased necroptosis in type 
 II alveolar epithelial cells causes pulmonary fibrosis11. Thus inhibition of necroptosis has been 
extensively studied as a potential therapeutic strategy for disease-specific applications 12. 
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Acute pancreatitis (AP) is a local inflammatory reaction in the pancreas involving 
cholecystokinin-stimulated pancreatic enzyme secretion that damages pancreatic tissue 13 14, and 
elevations in serum levels of amylase and lipase are correlated with the disease 13. Although 
severe AP is fatal , a disease-specific treatment has not yet been identified. The severity of the 
disease is closely associated with massive acini necrosis 13 14. Regarding the contribution of 
pathophysiology of AP to thenecroptosis  , it is unclear whether inhibition of necroptosis 
mediated by RIPK3/MLKL is effective in protecting against pancreatic damage because 
different outcomes have been reported. Inhibition of necroptosis with the RIPK1 inhibitor 
necrostatin-1 or by genetic deletion of either Ripk3 or Mlkl provides protection against AP by 
reducing acinar cell vacuolization and necrosis 15 16 17 18 19. In contrast, necrotizing pancreatitis is 
accelerated in Ripk3-deficient mice 20.  ,Thuswe investigated the roles and consequences of 
RIPK3 and the MLKL-mediated necroptosis pathway in AP by using Ripk3- or Mlkl-deficient 
mice (Ripk3-/- or Mlkl-/- mice, respectively). We induced experimental AP in Ripk3-/- and Mlkl-
/- mice via administration of excessive doses of caerulein. Ripk3-/- and Mlkl-/- mice exhibited 
greater pancreatic edema and recruitment of inflammatory cells, including macrophages and 
neutrophils, into the pancreas than control mice. Inhibition of MLKL-driven cell death resulted 
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in increased apoptosis associated with the expression of antiapoptotic genes. These findings 




Materials and methods 
Mice 
Female C57BL/6 mice were purchased from Japan SLC (Hamamatsu, Japan). Ripk3-/- 
and Mlkl-/- mice have been previously described 11. week-to twelve -Six-old mice were used for 
the experimental and control groups. The mice were housed under specific pathogen-free 
conditions with unlimited access to food and water in the animal research center of Tokushima 
University. All animal experiments were performed according to protocols approved by the 
animal research committee of Tokushima University and the institution’s guidelines for animal 
care and use. 
 
Experimental AP 
Mice were randomly divided into control and experimental groups and then fasted 
overnight. The experimental groups were administered caerulein (Bachem, Bubendorf, 
Switzerland) by intraperitoneal injection in four different regimens (Supplementary Fig. 1), as 
follows: 
(A) Caerulein (50 µg/kg body weight) was administered every hour for eight consecutive 
hours, and mice were sacrificed 24 hours after the first injection. 
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(B) Caerulein (50 µg/kg body weight) was administered every hour for six consecutive hours 
on two days separated by 1 day of rest, and mice were sacrificed 24 hours after the first 
injection on the last day. 
(C) Caerulein (100 µg/kg body weight) was administered every hour for eight consecutive 
hours, and mice were sacrificed 24 hours after the first injection. 
 
For kinetic experiments, mice were injected with 100 µg/kg body weight caerulein every hour 
and sacrificed at 2, 4, 8 and 24 hours after the first injection. The total mouse body weight was 
measured before and after treatment. Blood plasma was collected by centrifugation at 3000 rpm 
for 10 min and was then used for determination of amylase and lipase activity. 
 
Serum lipase and amylase 
Serum lipase and amylase concentrations were determined by CLEA Japan Inc. (Tokyo, 





Pancreatic tissues were fixed in a 10% (v/v) neutral buffered formalin solution (Wako, 
Osaka, Japan) for 24 hours and embedded in paraffin. Paraffin sections were cut and stained with 
hematoxylin/eosin (H&E). The severity of AP was evaluated by two experienced pathologists 
blinded to the study protocol. The pancreatic structure, inflammation and necrosis were 
semiquantitatively analyzed according to a scoring system described previously (Supplementary 
Table 1). Apoptotic cells were analyzed using terminal deoxynucleotidyl transferase dUTP nick 
end labeling (TUNEL) staining according to the manufacturer’s instructions (Abcam, ab206386). 
For a positive control, sections were treated with 1 µg/µL DNase I in TBS/1 mM MgSO4 for 20 
min at room temperature. The specimens were examined by light microscopy (Olympus, BX53). 
 
Isolation of pancreatic cells 
 Pancreatic tissues were carefully removed and immediately resuspended in 3 ml of 
Hank’s balanced salt solution (HBSS; Wako, Osaka) on ice. The tissues were cut into small 
pieces and digested in HBSS containing 2.5 mg/ml collagenase P and 0.1 mg/ml DNase I for 30 
min at 37 °C. After incubation, the cells were washed with cold sterile PBS and collected by 
centrifugation at 1500 rpm for 10 min. The cell pellets were resuspended in cold HBSS medium, 
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filtered through a 100-µm strainer (BD Falcon, no. 352360) and further collected by 
centrifugation at 1500 rpm for 10 min. The cells were counted with a hemocytometer, and a 
Countess II FL automated cell counter (Invitrogen) was used. For edema analysis, whole 
pancreas samples were weighed and dried at 95 °C for 48 hours. Edema was calculated 
following desiccation and is expressed as a percentage of the wet weight (wet weight – dry 
weight/wet weight × 100). 
 
Flow cytometry 
To block the Fc receptor, isolated pancreatic cells were incubated with the 2.4G2 
antibody for 15 min at 4 °C and then washed twice in FACS buffer (PBS containing 0.5 %  FBS, 
0.05% NaN3). The cells were stained with 50 µl of an antibody cocktail for 15 min at 4 °C in the 
dark. Live and dead cells were discriminated using 7AAD (BioLegend). Fluorochrome-
conjugated antibodies against the following proteins were used: CD3 (BioLegend, 145-2C11), 
CD4 (BioLegend, GK1.5), CD8 (BioLegend, 53-6.7), CD11b (BioLegend, M1/70), CD11c 
(eBioscience, N418), CD19 (BioLegend, eBio1D3), F4/80 (BioLegend, BM8), CD45 
(BioLegend, 30-F11), Ly6G (BioLegend, 1A8), and CD206 (BioLegend, C068C2). After 
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incubation with antibodies, the stained cells were washed twice in FACS buffer and then fixed 
with 4 % paraformaldehyde (Wako, Osaka, Japan). The data were assessed using the BD 
FACSCanto II system (BD Biosciences) and analyzed with FlowJo (TreeStar, Ashland, OR). 
 
Real-time quantitative PCR (qPCR) 
 Pancreatic tissue was immediately placed in RNAlaterTM solution (Invitrogen, no. 
AM7020) after snap-freezing in liquid nitrogen. Total RNA was first extracted with TRIzol 
reagent (Takara, no. 9109) followed by a ReliaPrepTM RNA Tissue Miniprep system according to 
the manufacturer’s instructions (Promega, Madison, WI, USA). RNA integrity was observed 
using agarose gel electrophoresis. Then, cDNA was synthesized using ReverTra Ace® qPCR RT 
Master Mix according to the manufacturer’s instructions (Toyobo, Osaka, Japan). mRNA 
expression was analyzed by qPCR on a Step-One RT-PCR system (Applied Biosystems) using 
SYBR green incorporation. The raw data were analyzed by the 2-ΔΔCT method and normalized to 





Fresh pancreatic tissues were homogenized in RIPA buffer (Nacalai Tesque, Kyoto, Japan) 
containing phosphatase inhibitor cocktail (Roche, Basel, Switzerland), protease inhibitor cocktail 
(Roche, Mannheim, Germany), and 1 mmol/L phenylmethylsulfonyl fluoride (Sigma, St. Louis, 
USA). Protein concentration was measured using the Pierce BCA Protein Assay Kit (Thermo. 
Scientific, no 23225). Total protein was denatured in loading buffer containing SDS at 95 °C for 
5 min. Fifty micrograms of denatured protein was loaded and separated on a sodium dodecyl-
sulfate polyacrylamide gel electrophoresis gel and transferred to a polyvinylidene difluoride 
membrane. Membranes were probed with the following antibodies: anti-p-Ripk3 (#ab195117, 
Abcam) and beta-actin (#sc-47778, Santa Cruz). All primary antibodies were used at a dilution 
of 1:1000. Anti-rabbit IgG horseradish peroxidase and anti-mouse-IgG horseradish peroxidase 
secondary antibodies were used. All secondary antibodies were used at a dilution of 1:10000. 






 The data are presented as the mean ± standard error of the mean (SEM). Statistical 
analysis was performed using paired Student’s t-tests. A P value of <0.05 was considered to 
indicate significance (*p<0.05, **p<0.01, ***p<0.001). 
 
Results 
Optimization of the protocol for caerulein hyperstimulation induced acute pancreatitis 
We optimized the protocol of caerulein-induced AP and compared the sensitivity of AP between 
control and Mlkl-/- mice. We first confirmed the absence of MLKL protein in Mlkl-/- mice by 
using two antibodies recognizing the C- terminal and N- terminal domains of MLKL (Fig. 1A). 
Next, we optimized the protocol to induce acute pancreatitis in vivo. Mlkl+/- and Mlkl-/- mice 
were starved overnight and then intraperitoneally injected with different doses of caerulein; eight 
hourly repeated injections with either 50 µg/kg or 100 µg/kg of caerulein for one day or six 
hourly repeated injections with 50 µg/kg of caerulein per day for two days separated by 1 day of 
rest. Mice were sacrificed 24 hr. after first injection (Supplementary Fig. 1A, B and C). The 
untreated group typically had normal pancreatic structure. Histological investigations showed 
that AP severity increased in a dose-dependent manner (Fig. 1B). Compared to control mice, 
Mlkl-/- mice receiving caerulein at a dose of 100 µg/kg developed the most severe AP (Fig. 1B). 
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Body weight was significantly decreased in Mlkl-/- mice receiving caerulein at dose of 100 µg/ 
kg (Fig. 1C). Pancreatic weight and the pancreas-to-body weight ratio tended to be elevated in 
caerulein-treated Mlkl-/- mice for all protocols (Fig. 1D and E). Thus, we took administrating 
high-dose cearulein (100 µg/ kg of caerulein for one day or six hourly repeated injections) in the 
following experiments because this protocol C induced the most severe form of AP. because this 
protocol induced strongest AP. Moreover, we evaluated the impact of sex differences on severely 
injured outcomes to determine the protocol because previous papers have used male and female 
mice for caerulein-induced AP models 21 22 23.  We did not see the gender difference in our 
protocol C (Fig 1F). Thus, we used female mice in the following experiments. 
MLKL-mediated necroptosis promotes AP 
The pseudokinase MLKL is a key protein that regulates necroptosis 24, 25. MLKL phosphorylated 
by RIPK3 forms oligomers and translocates to the cell membrane, where it causes pore 
formation 2, 24. We first investigated whether deletion of Mlkl attenuates AP. Mlkl+/- and Mlkl-/- 
mice received repeated injections of 100 µg/kg caerulein every hour for 8 hours (Fig. 2A). The 
pancreatic tissues were harvested 2, 4, 8, and 24 hours after the first injection. We observed that 
mice receiving caerulein for 7 hours (early) had significant body weight loss compared to control 
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mice (Fig. 2B). At 24 hours (late) after treatment, Mlkl-/- mice showed a trend toward higher 
pancreatic weight and the higher pancreas-to-body weight ratio (Fig. 2C and D). A similar result 
was observed in the wet-to-dry weight ratio, which showed significant increase in pancreatic 
edema (Fig. 2E). The absolute cell numbers in the caerulein-treated mice were slightly elevated 
at 8 hr. posttreatment and significantly peaked at 24 hr posttreatment (Fig. 2F), but there were no 
differences among the treatment groups. Histological investigations showed that AP severity 
increased in a time-dependent manner (Fig. 2G and H). The caerulein-treated mice progressively 
developed edematous pancreatitis and inflammation from 8 to 24 hours after the first injection 
(Fig. 2G and H). The pathological scores showed a tendency toward more edema, acinar necrosis 
and inflammation in Mlkl-/- mice than in control mice, but there was no statistical significance at 
either the early (8 hours) or late (24 hours) time point of specimen collection. These results 
indicate that Mlkl-/- mice tended to be more susceptible to caerulein-induced AP than control 
mice. 
 
Mlkl deficiency increased the expression of dedifferentiation-related genes 
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We next investigated the activity of pancreatic lipase and amylase in Mlkl-/- mice. The 
results showed increased serum levels of lipase and amylase in caerulein-treated Mlkl-/- and 
control mice, but the differences were not significant (Fig. 3A and B). As Mlkl-/- mice were 
sensitized to secretagogue-induced pancreatitis, we assessed the expression of genes associated 
with pancreatic functions and cell-specific markers (Fig. 3C and D). qPCR revealed significantly 
decreased expression levels of the pancreatic digestive enzymes amylase (Amy2), lipase (Pnlip), 
elastase (Celal), chymotrypsinogen (Ctrc) and insulin (Ins), but there were no differences 
between caerulein treated- Mlkl-/- and control mice (Fig. 3C). We then analyzed the expression 
of pancreatic tissue repair markers 26, including Nestin (Nes), Pdx1 (Pdx1), E-cadherin (Cdh1) 
and Cyclophilin (Ctnnb1). We detected lower E-cadherin expression in Mlkl-/- mice than in 
control mice (Fig. 3D). The expression of ductal markers, including cytokeratin 7 (Krt7) and 
cytokeratin 19 (Krt19), was comparable between Mlkl-/- and control mice (Fig. 3D). These data 
suggested that the reduced E-cadherin levels in pancreatic tissue in Mlkl-/- mice were involved in 
severe acinar cell damage and pancreatic inflammation. 
 
Mlkl deficiency reduces neutrophil infiltration associated with AP in mice 
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 Inflammatory cells in freshly isolated pancreatic tissue were analyzed by flow 
cytometry (Fig. 4A). The percentage of CD45+ cells tended to be higher in caerulein-treated 
Mlkl+/- mice than in Mlkl-/- mice (Fig. 4B). We also detected increased infiltration of dendritic 
cells, neutrophils and macrophages at 8 hours after the first injection (Supplementary Fig. 2). A 
small but significant increase in the percentage of CD3-CD19+ cells was detected in treated 
Mlkl+/- mice compared with Mlkl-/- mice 24 hours after the first injection (Fig. 4C), but the 
frequencies of CD3+ cells, macrophages and dendritic cells were comparable among the 
treatment groups (Fig. 4D, E and F). The frequencies of neutrophils were significantly higher 
(more than 2.5-fold higher) in caerulein-treated Mlkl+/- mice than in Mlkl-/- mice, but there were 
no differences in CD62L expression among the treatment groups (Fig. 4G and H). A previous 
study reported an association of the severity of pancreatitis with lung inflammation. Thus, we 
evaluated neutrophils in the lungs of caerulein-treated Mlkl+/- and Mlkl-/- mice and found 
decreased numbers of neutrophils in Mlkl-/- mice (Fig. 4I). 
We then evaluated inflammatory cytokine expression in macrophages or pancreatic 
tissues at  8 hours or  24 hours after the first treatment. We detected a tendency toward increased 
Il1b, Csf, Cxcl10 and Mcpt1 expression in the total pancreatic tissue of caerulein-treated Mlkl-/- 
19 
 
mice at 8 hours after the first injection (Fig. 4J) and detected significantly increased Il10 and Tnf 
expression at 24 hours after the first injection (Fig. 4J). Elevated expression of IL-10 but not 
TNF-α was detected in macrophages (Fig. 4K and L). These data suggest that mice lacking Mlkl 
developed AP because of increased proinflammatory cytokine- and chemokine-mediated 
recruitment of dendritic cells and macrophages into the inflamed pancreas. 
Deficiency of Ripk3  exacerbates AP 
RIPK3 kinase activity is essential for the regulation of MLKL-mediated necroptosis 1,21, 
22. Since Mlkl-/- mice developed stronger AP and pancreatic inflammation than control mice, we 
tested whether lack of RIPK3 expression affects AP. To examine whether RIPK3-dependent 
necroptosis contributes to the disease in vivo, Ripk3-/- mice were administered 100 µg/kg 
caerulein every hour for 8 hours. Twenty-four hours after the first administration, the results 
revealed no difference in body weight gain between saline- and caerulein-treated mice (Fig. 5A 
and B). AP manifested as a significant increase in absolute pancreatic weight (Fig. 5C) and 
pancreatic edema (Fig. 5D) in caerulein-treated Ripk3-/- mice compared with control mice. We 
observed acinar necrosis and pancreatic edema 8 hours after the first injection, but there were no 
differences in caerulein-treated control and Ripk3-/- mice (Fig. 5E). Blinded pathological 
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examination revealed that Ripk3-/- mice exhibited higher histological scores than control mice 
(Fig. 5E and F). These data indicated that Ripk3-/- mice exhibited edematous pancreatitis and 
necrotizing pancreatitis, which leads to more severe AP in these mice than in control mice. 
Ripk3-/- exacerbates inflammation associated with experimental AP in mice 
We then analyzed amylase and lipase activity and immune cell infiltration into pancreatic 
tissue in Ripk3-/- mice. Mice treated with caerulein exhibited significant increases in serum 
amylase and lipase activity and threefold and sevenfold increases in serum amylase and lipase 
levels, respectively (Fig. 6A and B). There were no statistically significant differences in serum 
pancreatic amylase and lipase levels between caerulein-treated Ripk3+/- and Ripk3-/- mice (Fig. 
6A and B). Flow cytometry analysis showed that caerulein-treated control mice had significantly 
increased CD45+ immune cell infiltration in pancreatic tissue (Fig. 6C and D). The percentages 
of dendritic cells (CD45+F80/4-CD11b+CD11c+ cells) and macrophages (CD45+F4/80+CD11b+ 
cells) were increased by caerulein treatment, but there were no differences between Ripk3+/- and 
Ripk3-/- mice (Fig. 6E and F). The ratio of M1 to M2 macrophages tended to be reduced by 
caerulein treatment, but there was no difference between Ripk3-/- and control mice (Fig. 6G and 
H). The elevated levels of pancreatic tissue damage in Ripk3-/- mice were associated with 
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significantly increased neutrophil (CD45+CD11b+Ly6Ghigh) infiltration (Fig. 6I). These data 
indicated that Ripk3-/- mice exhibited more severe AP with increased edema and more 
infiltration of neutrophils than control mice, suggesting that Ripk3 has protective roles in AP. 
 
Mlkl-/- increases apoptosis in acinar cells in mouse pancreatic tissue 
 We assessed whether the loss of necroptosis in Mlkl-/- mice was associated with 
apoptosis in acinar cells. A TUNEL assay showed a significant increase in the number of 
apoptotic cells in the pancreas in caerulein-treated Mlkl-/- mice (Fig. 7A and B). We then 
analyzed apoptosis-related mRNA expression 24 hours after the first treatment. The caerulein-
treated Mlkl+/- mice had increased mRNA expression levels of antiapoptotic genes, including 
Bclxl and Cflar (Fig. 7C). We next investigated the kinetics of RIPK3 phosphorylation. The 
caerulein-treated Mlkl+/- and Mlkl-/- mice had high levels of phosphorylated RIPK3 at all time 
points but there were no significant differences between the two (Fig. 7D). These data suggested 
that apoptosis occurrence was increased in acinar cells in caerulein-treated Mlkl-/- mice, and this 






AP is characterized by unpredictable inflammation of the pancreas, and in progressive 
severe cases, systemic complications develop that are associated with high mortality rates 27 28 29 
30. Improved treatment strategies for AP that are safer, more effective and less invasive than 
existing approaches are urgently needed. Currently, targeted inhibition of necroptosis is being 
explored as a therapeutic strategy for inflammatory diseases 12 because  various studies have 
reported the contribution of necroptosis to inflammatory responses 2 9 10 11. Thus, we 
investigated the roles of necroptosis in a mouse AP model in which genes related to necroptosis, 
specifically Ripk3 and Mlkl, were deleted. Compared with control mice, Ripk3-/- and Mlkl-/- 
mice exhibited increased pancreatic edema and recruitment of inflammatory cells together with 
increased apoptosis of acinar cells. These findings suggest that necroptosis exerts protective 
effects in AP by suppressing apoptosis in acinar cells. 
In this study, we investigated caerulein-induced pancreatic tissue damage in either Ripk3-
/- or Mlkl-/- mice. We obtained several lines of evidence indicating that the absence of 
necroptotic regulators sensitizes cells to the development of AP triggered by pancreatic exocrine 
signaling. First, deletion of Ripk3 led to increased cell swelling and inflammatory cell 
infiltration. Second, caerulein-treated Mlkl-/- mice exhibited reduced body weights, increased 
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pancreatic edema, and enhanced mRNA expression of proinflammatory cytokines and 
chemokines in the early phase of AP. The upregulation of these genes was associated with 
elevations in the numbers of infiltrating macrophages and dendritic cells. There were slight 
phenotypic differences between Ripk3-/- and Mlkl-/- mice such as increased neutrophil 
infiltration in Ripk3-/- mice and decreased neutrophil infiltration in Mlkl-/- mice. RIPK3 
regulates not only necroptosis but also apoptosis and other cellular functions including those 
related to NLRP3 inflammasomes 3 31, which might explain the phenotypic differences between 
Ripk3-/- and Mlkl-/- mice.  In addition, we observed that caerulein-treated Mlkl-/- mice showed 
significantly lower levels of Edh1expression than control mice. Although we still do not know 
how necroptosis affects Edh1 expression, it might be possible that the lower level of pancreatic 
tissue repair in Mlkl-/- mice with acute pancreatitis reflects less sensitivity to acinar cell damage 
and pancreatic inflammation. 
Previous studies have reported contradictory results regarding the roles of necroptosis in 
AP. Several studies have reported that inhibition of RIPK3 and MLKL leads to the protection of 
AP by reducing acinar cell vacuolization and necrosis 15 16 17 18 19, while another study has 
reported that AP development is accelerated in the absence of RIPK3 20. Here, we evaluated AP 
by using mice in which Ripk3 or Mlkl was deleted and found that the absence of either gene 
worsened the AP outcome. One possible explanation for the distinct outcomes would be the 
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different treatment schedules and amounts of caerulein used in these studies. If the schedule or 
dose of caerulein is the major reasons, necroptosis may contribute to AP pathology only in a 
particular time frame or restricted pancreatic area. If the window for observing the roles of 
necroptosis is very small, the outcome may fluctuate depending on the dose and timing of 
caerulein administration. 
We detected upregulation of Tnfα and Mcp1 at 1 hour after treatment and a high level of 
Il10 mRNA expression at 12 hours after treatment. These changes were associated with the 
enhanced migration of macrophages but not neutrophils into the pancreas in Mlkl-/- mice. One 
study suggested that IL-10 secreted from M2 macrophages suppresses the migration of 
neutrophils into the pancreas 32. As decreased neutrophil migration into the pancreas results in 
resistance to the development of AP 33the elevated expression of Il10 in macrophages in Mlkl-/- 
phil migrationmight also play roles in the suppression of neutromice . .  
Blockade of MLKL-driven necroptosis increased apoptosis of acinar cells by TUNEL 
assay and reduced the expression of antiapoptosis-related genes. RIPK1 is an upstream mediator 
of the necroptosis cascade, and in the absence of RIPK3, RIPK1 kinase-dependent activity can 
trigger cell death through FAAD-caspase8-mediated apoptosis 4. However, it remains unclear 
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whether the absence of MLKL also shifts the functions of RIPK1 toward increased apoptosis. 
One possibility is the enhancement of a feedback mechanism to suppress inflammation via 
increased apoptosis or secondary effects caused by increases in the levels of inflammatory 
mediators. In addition, as we could not detect cleaved caspase3 and 8 in total cell lysates of mice 
treated with caerulein (data not shown) probably because a few cells underto apoptosis by 
TUNEL assay, the roles of apoptosis together with other types of cell death including pyroptosis 
in the pathophysiology of AP in Mlkl-/- mice require further study in the future. 
In conclusion, the present findings suggest that necroptosis plays protective roles in 
mouse AP. Although conflicting results have been obtained depending on the timing and amount 
of caerulein, our data caution against the simple use of necroptosis inhibitors for AP treatment. 
Furthermore, histological analysis of human samples is needed to understand whether the data 
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Figure 1. Optimization of the protocol to induce acute pancreatitis in vivo. (A) Western blot 
of MLKL expression in splenocytes from Mlkl+/- and Mlkl-/- mice by using antibodies 
recognizing the C- terminal and N- terminal domains of MLKL. Mlkl+/- and Mlkl-/- mice 
received intraperitoneal injection of three doses of caerulein; 50 µg/ kg/ body weight at eight-
hour intervals, 50 µg/ kg/ body weight at six-hour intervals for two days and 100 µg/ kg/ body 
weight at eight-hour intervals. Twenty-four hours after the first injection, mice were sacrificed (n 
= 5-10 in each group). (B) Representative haematoxylin and eosin (H&E) images of pancreases 
from Mlkl+/- and Mlkl-/- mice treated with or without caerulein. (C) Total weight gain (grams) , 
(D)weight gain (grams)  and  (E) the ratio of pancreatic weight to the final body weight 
(milligrams to grams) were determined. (F) Representative H&E images of pancreases from 
male and female Mlkl-/- mice after receiving caerulein for 8 hours. Data are present as means ± 
SE. * P<0.05, ** P<0.01, and ***P<0.001.   
 
Figure 2. Mlkl-/- mice showed increased inflammation after caerulein treatment.  
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(A) Schematic diagram of caerulein-induced experimental AP in vivo. Mlkl+/- and Mlkl-/- mice 
were intraperitoneally injected with either 100 µg/kg caerulein or saline every hour for 8 
consecutive hours. The mice were sacrificed at 2, 4, 8 and 24 hours after the first injection. The 
total weight gain (B), pancreatic weight (C) and ratio of pancreatic weight to final body weight 
(D) were determined. (E) Pancreatic edema formation was determined by the wet/dry weight 
ratio in mice sacrificed at 8 hours after the last injection. The results are representative of three 
independent experiments with a minimum of five mice per group. (F) The cell number in each 
group was determined by automated cell counter. (G&H) Representative H&E images of the 
pancreas and histological scores of pancreatic edema, necrosis and inflammation were evaluated 
in mice sacrificed 8 hours and 24 hours after the first injection; saline or 100 µg/kg caerulein 
was injected every hour for 8 consecutive hours (n = 6-15 in each group). The data are presented 
as the means ± SEMs. * P<0.05, ** P<0.01, and ***P<0.001.  These data are representative of 
three experiments.  
 
Figure 3. In Mlkl-/- mice, pancreatic injury was by repaired via reductions in the 
expression of pancreatic digestive enzymes. Serum amylase (A) and lipase activity (B) were 
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determined in serum collected after 12 hours of treatment with saline or caerulein (n=5-6 in each 
group). The results of qPCR analysis of mRNA expression in pancreatic tissue are shown in (C) 
and (D). Pancreatic digestive enzyme genes (Amy2, Pnlip, Ctrc, Cela1, and Ins), genes associated 
with pancreatic development (Nes and Pdx1), and ductal and epithelial cell-associated genes 
(Cdh1, Ctnnb1, Krt7 and Krt19) were examined (n=6 in each group). The data are presented as 
the means ± SEMs. * P<0.05, ** P<0.01, and ***P<0.001 compared to the control group. These 
data are representative of three experiments. 
 
Figure 4. Low neutrophil infiltration was associated with mild AP in Mlkl-/- mice. (A) 
Representative dot plot of flow cytometry for the frequencies of CD45+CD11b+F4/80high 
macrophages, CD45+CD11b+Ly6Ghigh neutrophils, CD45+F4/80-CD11b+CD11c+ dendritic 
cells, and lymphocytes. (B-K): Bar plots showing the frequency of CD45+ cells (B), the 
frequency of CD3-CD19+ B cells (C), the frequency of CD3+ T cells (D), the frequency of 
CD45+CD11b+F4/80high macrophages (E), the frequency of CD45+F4/80-CD11b+CD11c+ 
dendritic cells (F), the frequency of pancreatic CD45+CD11b+Ly6Ghigh neutrophils (G), the 
frequency of lung CD45+CD11b+Ly6Ghigh neutrophils (I), the mean fluorescence intensity (MFI) 
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of CD62L on neutrophils (H), and the MFI of IL-10 and TNF-α on CD45+CD11b+F4/80high 
macrophages (J and K). The data are presented as the means ± SEMs (n = 10-15 
mice/genotype). * P<0.05, ** P<0.01, and ***P<0.001. (L) qPCR analysis of proinflammatory 
cytokine (Ilb, Il6, Il17, Il8, Ifng, Tnf, Il10, Csf1 and Csf2) and chemokine (Mcpt1 and Cxcl10) 
mRNA expression in pancreatic tissue (n=5 in each group) collected at 8 and 24 hours after the 
first injection. * P<0.05, ** P<0.01, and ***P<0.001 compared to the control group. 
 
Figure 5. Ripk3-/- mice exhibited exacerbated pancreatic tissue damage in vivo. Ripk3+/- 
and Ripk3-/- mice were intraperitoneally injected with either 100 µg/kg caerulein or saline every 
hour for 8 consecutive hours. The mice were sacrificed at 4, 8 and 24 hours after the first 
injection (n = 6-8 in each group). (A) The total body weight and (B) weight gain were 
determined. The pancreas weight is shown as the absolute weight (C) or as a percentage of the 
final body weight (D). (E) Representative H&E images of pancreas tissue. (F) Histological 
scores of pancreatic sections from Ripk3+/- and Ripk3-/- mice treated with caerulein showing 
pancreatic edema, acinar necrosis and inflammation. gnificant differnce in any There were no si
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parameter such as edema, and inflammation necroptosis.  The data are presented as the means ± 
SEMs. * P<0.05, ** P<0.01, and ***P<0.001. These data are representative of three experiments.  
 
Figure 6. The severity of AP in Ripk3-/- mice was associated with neutrophil infiltration. 
Amylase (A) and lipase activity (B) were determined in serum collected at 12 hours after the last 
injection of either PBS or caerulein. (C) Absolute CD45+ cell counts in freshly isolated 
pancreatic tissues from each group were determined by an automated cell counter. Flow 
cytometry analysis was performed to identify inflammatory immune cells in pancreatic tissue. D-
I: Bar plots showing the percentage of CD45+ cells (D), the percentage of CD45+F4/80-
CD11b+CD11c+ dendritic cells (E), the percentage of CD45+CD11b+F4/80high macrophages (F), 
the percentages of CD11c+CD206- M1-like macrophages and CD11c-CD206+ M2-like 
macrophages (G), the ratio of M1/M2 macrophages (H), and the percentage of 
CD45+CD11b+Ly6Ghigh neutrophils (I). The data are presented as the means ± SEMs. * P<0.05, 




Figure 7. Caerulein-induced AP leads to a higher level of apoptosis in Mlkl-/- mice than in 
Mlkl+/- mice. Pancreatic apoptosis was detected by terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL) staining. (A) Representative images of TUNEL-stained pancreatic 
sections from Mlkl-/- and Mlkl+/- mice treated with either saline or caerulein. Pancreatic sections 
were incubated with DNase I as a positive control (B) Number of TUNEL-positive cells per 
field. (C) qPCR analysis of the mRNA expression of proapoptotic genes (Bim, Bax, and Bid) and 
antiapoptotic genes (BclXL, Bcl2, and Cflar) in pancreatic tissue after 12 hours of treatment with 
saline or caerulein (n=6 in each group). (D) Kinetics of p-RIPK 3 during the course of cearulein 
treatment; mouse pancreatic tissue was collected at the indicated times and then cell lysates (50 
μg of protein) were analyzed by immunoblotting. The data are presented as the means ± SEMs. * 









1. Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature 2015, 
517(7534): 311-320. 
 
2. Choi ME, Price DR, Ryter SW, Choi AMK. Necroptosis: a crucial pathogenic mediator of 
human disease. JCI Insight 2019, 4(15). 
 
3. Christofferson DE, Li Y, Yuan J. Control of life-or-death decisions by RIP1 kinase. Annu 
Rev Physiol 2014, 76: 129-150. 
 
4. Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death 
pathways and its physiological implications. Nat Rev Mol Cell Biol 2020. 
 
5. Schwarzer R, Laurien L, Pasparakis M. New insights into the regulation of apoptosis, 
necroptosis, and pyroptosis by receptor interacting protein kinase 1 and caspase-8. Curr 
Opin Cell Biol 2020, 63: 186-193. 
 
6. Wallach D, Kang TB, Dillon CP, Green DR. Programmed necrosis in inflammation: 
Toward identification of the effector molecules. Science 2016, 352(6281): aaf2154. 
 
7. Petrie EJ, Czabotar PE, Murphy JM. The Structural Basis of Necroptotic Cell Death 
Signaling. Trends Biochem Sci 2019, 44(1): 53-63. 
 
8. Galluzzi L, Kepp O, Chan FK, Kroemer G. Necroptosis: Mechanisms and Relevance to 
Disease. Annu Rev Pathol 2017, 12: 103-130. 
 
9. Yuan J, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in 




10. Anderton H, Wicks IP, Silke J. Cell death in chronic inflammation: breaking the cycle to 
treat rheumatic disease. Nat Rev Rheumatol 2020, 16(9): 496-513. 
 
11. Takezaki A, Tsukumo SI, Setoguchi Y, Ledford JG, Goto H, Hosomichi K, et al. A 
homozygous SFTPA1 mutation drives necroptosis of type II alveolar epithelial cells in 
patients with idiopathic pulmonary fibrosis. J Exp Med 2019, 216(12): 2724-2735. 
 
12. Degterev A, Ofengeim D, Yuan J. Targeting RIPK1 for the treatment of human diseases. 
Proc Natl Acad Sci U S A 2019, 116(20): 9714-9722. 
 
13. Sah RP, Dawra RK, Saluja AK. New insights into the pathogenesis of pancreatitis. Curr 
Opin Gastroenterol 2013, 29(5): 523-530. 
 
14. Lerch MM, Gorelick FS. Models of acute and chronic pancreatitis. Gastroenterology 
2013, 144(6): 1180-1193. 
 
15. He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-
3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137(6): 1100-1111. 
 
16. Linkermann A, Brasen JH, De Zen F, Weinlich R, Schwendener RA, Green DR, et al. 
Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-
alpha-induced shock. Mol Med 2012, 18: 577-586. 
 
17. Wu J, Huang Z, Ren J, Zhang Z, He P, Li Y, et al. Mlkl knockout mice demonstrate the 
indispensable role of Mlkl in necroptosis. Cell Res 2013, 23(8): 994-1006. 
 
18. Louhimo J, Steer ML, Perides G. Necroptosis Is an Important Severity Determinant and 
Potential Therapeutic Target in Experimental Severe Pancreatitis. Cell Mol 




19. Duan PY, Ma Y, Li XN, Qu FZ, Ji L, Guo XY, et al. Inhibition of RIPK1-dependent 
regulated acinar cell necrosis provides protection against acute pancreatitis via the 
RIPK1/NF-kappaB/AQP8 pathway. Exp Mol Med 2019, 51(8): 1-17. 
 
20. Newton K, Dugger DL, Maltzman A, Greve JM, Hedehus M, Martin-McNulty B, et al. 
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL 
deficiency in mouse models of inflammation and tissue injury. Cell Death Differ 2016, 
23(9): 1565-1576. 
 
21. Ding SP, Li JC, Jin C. A mouse model of severe acute pancreatitis induced with caerulein 
and lipopolysaccharide. World J Gastroenterol 2003, 9(3): 584-589. 
 
22. Ma X, Conklin DJ, Li F, Dai Z, Hua X, Li Y, et al. The oncogenic microRNA miR-21 
promotes regulated necrosis in mice. Nat Commun 2015, 6: 7151. 
 
23. Ren Z, Li H, Zhang M, Zhao Y, Fang X, Li X, et al. A Novel Derivative of the Natural 
Product Danshensu Suppresses Inflammatory Responses to Alleviate Caerulein-Induced 
Acute Pancreatitis. Front Immunol 2018, 9: 2513. 
 
24. Newton K, Manning G. Necroptosis and Inflammation. Annu Rev Biochem 2016, 85: 
743-763. 
 
25. Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, et al. Mixed lineage kinase domain-like is 
a key receptor interacting protein 3 downstream component of TNF-induced necrosis. 
Proc Natl Acad Sci U S A 2012, 109(14): 5322-5327. 
 
26. Guo L, Sans MD, Hou Y, Ernst SA, Williams JA. c-Jun/AP-1 is required for CCK-
induced pancreatic acinar cell dedifferentiation and DNA synthesis in vitro. Am J Physiol 




27. Gukovskaya AS, Gukovsky I, Algul H, Habtezion A. Autophagy, Inflammation, and 
Immune Dysfunction in the Pathogenesis of Pancreatitis. Gastroenterology 2017, 153(5): 
1212-1226. 
 
28. van Dijk SM, Hallensleben NDL, van Santvoort HC, Fockens P, van Goor H, Bruno MJ, 
et al. Acute pancreatitis: recent advances through randomised trials. Gut 2017, 66(11): 
2024-2032. 
 
29. Vivian E, Cler L, Conwell D, Cote GA, Dickerman R, Freeman M, et al. Acute 
Pancreatitis Task Force on Quality: Development of Quality Indicators for Acute 
Pancreatitis Management. Am J Gastroenterol 2019, 114(8): 1322-1342. 
 
30. Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, et 
al. Acute pancreatitis. Lancet 2020, 396(10252): 726-734. 
 
31. Lawlor KE, Khan N, Mildenhall A, Gerlic M, Croker BA, D'Cruz AA, et al. RIPK3 
promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat 
Commun 2015, 6: 6282. 
 
32. Pan LL, Deng YY, Wang R, Wu C, Li J, Niu W, et al. Lactose Induces Phenotypic and 
Functional Changes of Neutrophils and Macrophages to Alleviate Acute Pancreatitis in 
Mice. Front Immunol 2018, 9: 751. 
 
33. Sakuma Y, Kodama Y, Eguchi T, Uza N, Tsuji Y, Shiokawa M, et al. Chemokine CXCL16 

































































































































































H. I. K. L.
J.
*
*
*
*
*
*
*
**
*
*
*
**
Figure 4
*
E.
A. B.
**
***
C.
D.
F.
*
**
**
Figure 5
Salin
e
4
h
r.
8
h
r.
Ripk3+/‐ Ripk3‐/‐
2
4
 h
r.
*
*
B. C.
G. H. I.
A.
*
*
D. E. F.
***
*
***
**
**
**
*
*
Figure 6
Saline Positive
control
Mlkl+/‐Caerulein Mlkl‐/‐ Caerulein
A. B.
C.
*
Figure 7
D.
****** **
***
***
** ** *
**
**
0
 h
r
2
 h
r
4
h
r
8
h
r
2
4
 h
r
0
 h
r
2
 h
r
4
h
r
8
h
r
2
4
 h
r
Mlkl+/‐ Mlkl‐/‐
Beta actin 42 kDa
pRIPK3 54 kDa
